社区

SENSYNE HEALTH.

LSE

- -

- -

- -

- -

- -

- -

Sensyne Health plc, a healthcare technology company, engages in the development and commercialization of clinically validated software in the United Kingdom. Its products include SEND, an early warning system for monitoring patient vital signs in hospital; GDm-Health, a prescribed digital therapeutic for the management of gestational diabetes at home; EDGE, a prescribed digital therapeutic for monitoring chronic obstructive pulmonary disease at home; CleanSpace, a system for monitoring personal exposure to air pollution; and Support-HF, a prescribed digital therapeutic for monitoring heart failure at home. The company has strategic research alliance with Bayer's LifeHub UK to develop new treatments using clinical artificial intelligence. Sensyne Health plc was incorporated in 2018 and is headquartered in Oxford, the United Kingdom.